logo
Sign in

HQL Stock Price, Chart, Stats & News

Tekla Life Sciences Investors
Save

Tekla Life Sciences Investors (HQL) is a dividend-paying stock with a current dividend yield of 12.11% as of Sep 29, 2026. It pays $2.24 per share over the trailing twelve months and distributes quarterly. Its dividend has grown at a 5.80% 5-year compound annual rate.

562.24M
Market cap
2.77x
Current P/E
–
Forward P/E
12.11%
Dividend yield

Dividend safety

Strong

Dividend coverage looks healthy — HQL pays out about 34% of earnings.

See the safety analysis

HQL chart

Fundamentals

Gross margin
30.80%
Operating margin
286.92%
Pretax margin
286.92%
Net margin
286.92%
Effective tax rate
–
ROA
16.61%
ROE
18.82%
D/E
–
Interest coverage ratio
–

HQL valuation

P/E
2.77x
P/S
15.53x
P/B
0.90x
P/CF
-199.72x
P/FCF
-199.72x
P/OCF
-199.72x
PEG
0.01x
EV multiple
5.41x

About

Tekla Life Sciences Investors, a closed-ended equity mutual fund, is expertly managed by Tekla Capital Management LLC. This U. S.-domiciled fund, which commenced operations on February 20, 1992, and was formerly known as H&Q Life Sciences Investors, seeks investment opportunities in publicly traded companies worldwide.

Related lists

Similar securities

Based on sector and market capitalization

Report issue